2002
DOI: 10.1002/1522-2675(200201)85:1<96::aid-hlca96>3.0.co;2-7
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Hexahydro-2-pyrindine (=Hexahydrocyclopenta[c]pyridine) Derivatives as Conformationally Restricted Analogs of the Nicotinic Ligands Arecolone and Isoarecolone

Abstract: Two hexahydropyrindine derivatives, 1,2,3,4,6,7-hexahydro-2-methyl-5H-cyclopenta[c]pyridin-5-one (1) and 1,2,3,4,5,6-hexahydro-2-methyl-7H-cyclopenta[c]pyridin-7-one (2), and their methiodides 14 and 26, respectively, were synthesized. They can be considered rigid analogues of the known nicotinic agonists arecolone ( 1-(1,2,5,6-tetrahydro-1-methylpyridin-3-yl)ethanone) and isoarecolone ( 1-(1,2,3,6-tetrahydro-1-methylpyridin-4-yl)ethanone). The affinity for the central nicotinic receptor were measured on rat c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…Cross couplings with the aryl bromide moiety can be achieved with aryl or heteroaryl boron reagents ( 15 a , b ). Allylic oxidation affords enone 16 , [35] while DIBAL reduction generates hemiaminal ether 17 [36] . The fused 5,5‐ring system allows for diastereoselective transformations.…”
Section: Resultsmentioning
confidence: 99%
“…Cross couplings with the aryl bromide moiety can be achieved with aryl or heteroaryl boron reagents ( 15 a , b ). Allylic oxidation affords enone 16 , [35] while DIBAL reduction generates hemiaminal ether 17 [36] . The fused 5,5‐ring system allows for diastereoselective transformations.…”
Section: Resultsmentioning
confidence: 99%
“…Other carbamates have been reported Saraswati et al, 1994). A cyclic analog I had quite low affinity for α 4 β 2 receptors (Guandalini et al, 2002). Another analog AG-4 also had low affinity .…”
Section: Acetylcholine-based Nicotine Agonistsmentioning
confidence: 90%
“…Recently, the affinity of novel rigid analogs of arecoline (11) and isoarecoline (12) such as (13) for central nAChRs was evaluated in vitro, providing information on the molecular requirements for developing new active compounds [15]. On the other hand, new 3-substituted quinuclidines (14) were patented as nicotinic agonists [16].…”
Section: Ach Release Enhancers: Nicotinic Stimulationmentioning
confidence: 99%